ELCC Updates in Immunotherapy and Beyond for Non–Small Cell Lung Cancer - Episode 7
Jarushka Naidoo, MD, M.B.B.Ch., explains the 5-year-data update from a study investigating single-agent pembrolizumab vs chemotherapy for advanced NSCLC.
Sponsored in part by Regeneron. Content independently created by OncLive.